Ann Arbor, USA and Zurich, Switzerland – Essen BioScience Inc. – a specialty provider of cell-based assay solutions and contract research services – and Nycomed – a privately owned global pharmaceutical company headquartered in Zurich, Switzerland – are pleased to announce a joint discovery agreement to identify novel small molecule ion channel modulators as pain […]
SAN DIEGO — Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today announced the appointment of Saiid Zarrabian as President & CEO. A senior life sciences executive with strong leadership and operations experience in both public and private companies, Zarrabian has […]
Tools and Reagents Pre-Configured to Support Cell Therapy Clinical Translation CARLSBAD, Calif. — –LifeTechnologies Corporation (NASDAQ:LIFE) today announced the formation of GIBCO(R)Cell Therapy Systems (CTS(TM)), which will offer the life science industry’s widest array of products to support cell therapy applications, including regenerative medicine. Specifically designed to help cell therapy practitioners accelerate the transition from […]
Systems Complement the Beckman Coulter Cell Analysis Portfolio Orange County, Calif. — Beckman Coulter, Inc., has entered into a strategic alliance with CaridianBCT, under the terms of which Beckman Coulter will market CaridianBCT cell therapy products in specific, targeted markets. CaridianBCT and Beckman Coulter will launch CaridianBCT’s Quantum Cell Expansion System, a closed system that […]
Madison, WI USA — Cellular Dynamics International (CDI) and Promega have entered into a research collaboration with the goal of bringing more relevant and highly predictive toxicity testing to the drug discovery process. Pharmaceutical discovery scientists will now be able to combine bioassays with human cardiomyocytes to improve prediction of unintentional, detrimental side effects that […]
A Virus-Free Technology for Reprogramming Cells. STEMCELL Technologies Inc announced today that they have signed a licensing agreement with Stanford University for a virus-free technique used for the generation of induced pluripotent stem cells. This technology will soon be commercially released by STEMCELL Technologies as STEMcircles™. STEMcircles™ is a new and simple technology, published in […]
COSTA MESA, Calif. — — DV Biologics LLC announced today that it has executed an agreement with System Biosciences LLC for the development of human-derived disease-specific induced pluripotent stem cell (iPSC) lines. iPSCs are pluripotent cells which are developed from non-pluripotent cells that have undergone gene expression changes to render them pluripotent giving them the […]
SAN DIEGO — — Cytori Therapeutics (NASDAQ: CYTX) entered into a $20 million secured loan facility from GE Capital, Healthcare Financial Services, Oxford Finance Corporation, and Silicon Valley Bank. The loan funded June 14, 2010. The funds will be used to support Cytori’s commercialization and clinical development activities in Europe, Asia and the United States. […]
Fort Collins, CO — / b3c newswire / – InVitria announced the launch of ITSE Animal-Free™, a recombinant and defined cell culture media supplement that provides the ingredients essential for high performance cell culture. ITSE Animal-Free provides a solution for maximizing performance in a consistent and animal-free system. Insulin and transferrin supplements are commonly used […]
Simple solution for long term live cell imaging Adding to Nikon’s groundbreaking series of BioStation incubator imaging systems, which offer excellent cell care throughout imaging, the new BioStation IM-Q allows users with minimal microscopy experience to conduct live cell imaging without a steep learning curve. This compact system incorporates a microscope, an incubator and a […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
